Home Categories Biochemical Engineering AM1241
A0789612

AM1241 , ≥98% , 444912-48-5

Synonym(s):
(R,S)-3-(2-Iodo-5-nitrobenzoyl)-1-(1-methyl-2-piperidinylmethyl)-1H-indole

CAS NO.:444912-48-5

Empirical Formula: C22H22IN3O3

Molecular Weight: 503.33

MDL number: MFCD11045986

Pack Size Price Stock Quantity
1MG RMB127.20 In Stock
5MG RMB359.20 In Stock
10MG RMB679.20 In Stock
25MG RMB1519.20 In Stock
50mg RMB2639.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Boiling point: 630.7±55.0 °C(Predicted)
Density  1.60±0.1 g/cm3(Predicted)
storage temp.  Store at -20°C
solubility  DMSO: ~18mg/mL at 60°C
pka 9.73±0.10(Predicted)
form  solid
color  yellow

Description and Uses

AM1241 is a cannabinoid (CB) receptor agonist that is selective for CB2 over CB1 with Ki values of 7.1 and 580 nM for human recombinant receptors transfected into HEK and CHO cells, respectively, in a radioligand binding assay. It is considered a protean agonist as it has neutral antagonist and partial agonist activity, depending on the assay utilized. It is also acts in a species-dependent manner in vitro, acting as an agonist at human CB2 receptors (EC50 = 190 nM) but an inverse agonist at rat and mouse CB2 receptors (EC50s = 216 and 463 nM, respectively). AM1241 produces antinociception to thermal stimuli in rat hindpaw. The antinociceptive actions of AM1241 were blocked by the CB2 receptor-selective antagonist AM630 but not by the CB1 receptor-selective antagonist AM251 . AM1241 is neuroprotective, preventing HIV-1 glycoprotein Gp120-induced apoptosis in primary human and murine neural progenitor cells and increasing cell survival and differentiation. It increases hippocampal neurogenesis and decreases astro- and gliogenesis in GFAP/Gp120 transgenic mice when administered at a dose of 10 mg/kg daily for ten days. AM1241 also delays motor impairment in a murine model of amytrophic lateral sclerosis (ALS).

(R,S)-AM1241 has been used as a cannabinoid CB2 agonist:

  • to study its inhibitory effect on bone cancer-induced pain and bone loss
  • to study the effect of its interaction with 17βestradiol on proliferation activity in primary human osteoblasts
  • to evaluate the sites of CB2 mediated antinociception in vivo.

Safety

Symbol(GHS) 
GHS07,GHS08
Signal word  Danger
Hazard statements  H315-H319-H334-H335
Precautionary statements  P302+P352-P305+P351+P338
Hazard Codes  Xn
Risk Statements  36/37/38-42/43
Safety Statements  22-26-36/37-45
WGK Germany  3

RELATED PRODUCTS